165 related articles for article (PubMed ID: 26012870)
1. Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation.
Baroni M; Pavani G; Pinotti M; Branchini A; Bernardi F; Camire RM
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1351-6. PubMed ID: 26012870
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
Qureshi SH; Yang L; Rezaie AR
Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
[TBL] [Abstract][Full Text] [Related]
3. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
4. Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.
Chen L; Manithody C; Yang L; Rezaie AR
Protein Sci; 2004 Feb; 13(2):431-42. PubMed ID: 14739327
[TBL] [Abstract][Full Text] [Related]
5. The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.
Ding Q; Shen Y; Yang L; Wang X; Rezaie AR
Thromb Haemost; 2013 Jul; 110(1):53-61. PubMed ID: 23677006
[TBL] [Abstract][Full Text] [Related]
6. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
[TBL] [Abstract][Full Text] [Related]
7. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
Wilkinson FH; Ahmad SS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
[TBL] [Abstract][Full Text] [Related]
9. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
Ahmad SS; London FS; Walsh PN
J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
11. Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency.
Pinotti M; Marchetti G; Baroni M; Cinotti F; Morfini M; Bernardi F
Thromb Haemost; 2002 Aug; 88(2):236-41. PubMed ID: 12195695
[TBL] [Abstract][Full Text] [Related]
12. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
Fang H; Zögg T; Brandstetter H
FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
Ahmad SS; Scandura JM; Walsh PN
J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
15. Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysis.
Cook BC; Rudolph AE; Kurumbail RG; Porche-Sorbet R; Miletich JP
J Biol Chem; 2000 Dec; 275(49):38774-9. PubMed ID: 10995746
[TBL] [Abstract][Full Text] [Related]
16. Factor VIIIa regulates substrate delivery to the intrinsic factor X-activating complex.
Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
FEBS J; 2006 Jan; 273(2):374-87. PubMed ID: 16403024
[TBL] [Abstract][Full Text] [Related]
17. Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X.
Yang L; Manithody C; Rezaie AR
J Thromb Haemost; 2009 Oct; 7(10):1696-702. PubMed ID: 19691479
[TBL] [Abstract][Full Text] [Related]
18. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
Ndonwi M; Broze G; Bajaj SP
J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
[TBL] [Abstract][Full Text] [Related]
20. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
